Duke University's TTO processed a record number of patents and invention disclosures, and also reported growth at its digital innovations unit.

4490 Ventures, a VC firm aligned to University of Wisconsin-Madison, backed a series A extension intended to advance in-venue digital marketing technology company UpShow's product and recruitment plans.

UT Southwestern-founded Taysha Gene Therapies surpassed its goal after underwriters bought additional shares.

Profile of Amy Banse, former managing director and head of funds, Comcast Ventures

Roche has injected funding into Palladio, creators of a drug for autosomal dominant polycystic kidney disease.

OUP has injected follow-on funding into Palladio, creators of a drug for autosomal dominant polycystic kidney disease.

GV has thrown its weight behind Monte Rosa Therapeutics, which is working on biotechnology to degrade disease-driving proteins that have hitherto been considered undruggable.

University of London-linked Monte Rosa Therapeutics is working on biotechnology to degrade disease-driving proteins that have hitherto been considered undruggable.

Novo and Bristol Myers-Squibb formed part of a group of new and existing backers that provided cash to Galecto, based on research from the universities of Lund and Edinburgh.

A group of new and existing backers have provided cash to Galecto, based on research from the universities of Lund and Edinburgh.